ArticleMolecular and clinical oncology2020

High cholinesterase predicts tolerance to sorafenib treatment and improved prognosis in patients with transarterial chemoembolization refractory intermediate stage hepatocellular carcinoma.

Shintaro Takaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.